BCR/ABL kinase interacts with and phosphorylates the RAD51 paralog, RAD51B

Leukemia

Volumn 23, Issue 12, 2009, Pages 2308-2310

  Slupianek, A ^a   Jozwiakowski, S K ^b,c   Gurdek, E ^b   Skorski, T ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Temple University   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; DNA BINDING PROTEIN; RAD51L1 PROTEIN, HUMAN;

BINDING SITE; CELL LINE; HUMAN; LETTER; METABOLISM; PHOSPHORYLATION;

BINDING SITES; CELL LINE; DNA-BINDING PROTEINS; FUSION PROTEINS, BCR-ABL; HUMANS; PHOSPHORYLATION;

EID: 74049125334     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2009.164     Document Type: Letter

References (9)

1. Skorski T. BCR/ABL, DNA damage and DNA repair: implications for new treatment concepts. Leuk Lymphoma 2008; 49: 610-614. (Pubitemid 351517197)
2. Holtz MS, Forman SJ, Bhatia R. Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli. Leukemia 2005; 19: 1034-1041. (Pubitemid 40862017)
3. Slupianek A, Schmutte C, Tombline G, Nieborowska-Skorska M, Hoser G, Nowicki MO et al. BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol Cell 2001; 8: 795-806. (Pubitemid 33030213)
4. Nowicki MO, Falinski R, Koptyra M, Slupianek A, Stoklosa T, Gloc E et al. BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood 2004; 104: 3746-3753. (Pubitemid 39564453)
5. Li X, Heyer WD. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res 2008; 18: 99-113.
6. Kawabata M, Kawabata T, Nishibori M. Role of recA/RAD51 family proteins in mammals. Acta Med Okayama 2005; 59: 1-9. (Pubitemid 40459842)
7. Van Etten RA, Debnath J, Zhou H, Casasnovas JM. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro. Oncogene 1995; 10: 1977-1988.
8. Ren R. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 2005; 5: 172-183. (Pubitemid 40314949)
9. Chen G, Yuan SS, Liu W, Xu Y, Trujillo K, Song B et al. Radiationinduced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J Biol Chem 1999; 274: 12748-12752.